Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 94

Sort by

Sort Order Select

Journal Articles

An Open-Label, Phase 2 Study of KRT-232, a First-in-Class, Oral Small Molecule Inhibitor of MDM2, for the Treatment of Patients with Myelofibrosis (MF) Who Have Previously Received Treatment with a JAK Inhibitor

Regina Garcia-Delgado, MD, Donal P. McLornan, MB, BCh (Hons), MRCP, PhD FRCPath, László Rejtő, Eric Jourdan, MD, Haifa Kathrin Al-Ali, MD, Andrzej Pluta, MD, Marek Hus, MD PhD, Joanne Ewing, PhDBMBS BSc FRPATH, Irum Khan, MD, Holger Hebart, Philipp J. Jost, MD, Sebastian Grosicki, MD PhD, Wayne M. Rothbaum, Jesse McGreivy, Srdan Verstovsek, MD PhD

Blood (2019) 134 (Supplement_1): 2945.

https://doi.org/10.1182/blood-2019-123836

Published: 2019

Journal Articles

The Gut Microbiome Regulates Psychological Stress-Induced Inflammation in Sickle Cell Disease

Chunliang Xu, PhD, Sungkyun Lee, PhD, Paul S. Frenette, MD

Blood (2019) 134 (Supplement_1): 205.

https://doi.org/10.1182/blood-2019-122331

Published: 2019

Journal Articles

Immune Tolerance Induction (ITI) in Paediatric and Adult Patients with Haemophilia a (HA) and High-Titre (HT) Factor VIII (FVIII) Inhibitor - Real Life Data

Magdalena Katarzyna Letowska, Krystyna Zawilska, MD PhD, Anna Klukowska, MD PhD, Krzysztof Chojnowski, MD PhD, Joanna Zdziarska, MD PhD, Ewa Stefanska-Windyga, MD PhD, Jerzy Windyga

Blood (2019) 134 (Supplement_1): 4942.

https://doi.org/10.1182/blood-2019-122422

Published: 2019

Journal Articles

Analysis of Predictive Factors for Early Response to Ruxolitinib in 266 Patients with Myelofibrosis from the Polish Adult Leukemia Group (PALG) Registry

Blood (2019) 134 (Supplement_1): 4180.

https://doi.org/10.1182/blood-2019-125864

Published: 2019

Journal Articles

miR106a-363 Cluster Has Oncogenic Potential in Childhood T-Cell Acute Lymphoblastic Leukemia

Monika Drobna, MSc, Bronislawa Szarzynska-Zawadzka, Maria Kosmalska, Roman Jaksik, PhD, Tomasz Szczepanski, MD PhD, Michał Witt, MD PhD, Małgorzata Dawidowska, PhD

Blood (2018) 132 (Supplement 1): 5142.

https://doi.org/10.1182/blood-2018-99-111103

Published: 2018

Journal Articles

Staining Pattern of Leukemic Lymphoblasts for Coagulation Factor XIII Subunit a Correlates with Clinical Outcome and B-Other Genotype in Childhood Acute Lymphoblastic Leukemia

Csongor Kiss, MD PhD DSc, Bettina Kárai, MD, Katalin Gyurina, MSc, BSc, Anikó Ujfalusi, MD PhD, Sędek Łukasz, PhD, Gábor Barna, PhD, Pál Jáksó, MD PhD, Peter Svec, MD PhD, Gábor Kovács, MD PhD DSc, Alexandra Kolenova, MD PhD, Jerzy Kowalczyk, MD, János Kappelmayer, MD PhD DSc, Zsuzsanna Hevessy, MD PhD, Tomasz Szczepanski, MD PhD

Blood (2018) 132 (Supplement 1): 5285.

https://doi.org/10.1182/blood-2018-99-118203

Published: 2018

Journal Articles

The Prognostic Impact of t(14;16) in Multiple Myeloma: A Multicenter Retrospective Study of 213 Patients. Is It Time to Revise the Revised ISS?

Blood (2018) 132 (Supplement 1): 4452.

https://doi.org/10.1182/blood-2018-99-115971

Published: 2018

Journal Articles

Outcome of Children Relapsing after First Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Acute Myeloid Leukemia: A Retrospective I-BFM Analysis of 336 Children between 2005 and 2016

Blood (2017) 130 (Supplement 1): 272.

https://doi.org/10.1182/blood.V130.Suppl_1.272.272

Published: 2017

Journal Articles

Concomitant Medications and Comorbidities Affect Early Response in CML Patients Treated with Imatinib: A Retrospective Analysis of 340 Patients from the Polish Adult Leukemia Group (PALG) Registry

Joanna Gora Tybor, Tomasz Sacha, Joanna Waclaw, Joanna Niesiobedzka-Krezel, Olga Grzybowska-Izydorczyk, Ewa Medras, Izabela Deren-Wagemann, Elzbieta Patkowska, Ilona Seferynska, Krzysztof Lewandowski, Anna Wache, Beata Blajer-Olszewska, Marzena Watek, Ewa Wasilewska, Tomasz Stoklosa, Krzysztof Warzocha, Krzysztof Jamroziak

Blood (2017) 130 (Supplement 1): 2887.

https://doi.org/10.1182/blood.V130.Suppl_1.2887.2887

Published: 2017

Journal Articles

Improvement of the Treatment Results in Childhood Acute Myeloid Leukemia in Poland from 1983 to 2017

Blood (2017) 130 (Supplement 1): 3866.

https://doi.org/10.1182/blood.V130.Suppl_1.3866.3866

Published: 2017

Journal Articles

miRNA Profiling in Pediatric T-ALL with Use of Next-Generation Sequencing: Focus on T-ALL Pathobiology and Heterogeneity

Małgorzata Dawidowska, PhD, Bronisława Szarzyńska-Zawadzka, Roman Jaksik, PhD, Monika Drobna, Maria Kosmalska, Sędek Łukasz, PhD, Tomasz Szczepański, MD PhD, Michał Witt, MD PhD

Blood (2017) 130 (Supplement 1): 1443.

https://doi.org/10.1182/blood.V130.Suppl_1.1443.1443

Published: 2017

Journal Articles

PTEN Alterations Are Related to Unfavorable Prognosis in Children with T-Cell Acute Lymphoblastic Leukemia Treated According to ALL IC-BFM Protocols

Bronisława Szarzyńska-Zawadzka, Joachim B. Kunz, MD, Maria Kosmalska, Katarzyna Zdon, Przemysław Biecek, PhD, Obul Reddy Bandapalli, PhD, Sędek Łukasz, PhD, Jerzy R. Kowalczyk, Prof, MD PhD, Tomasz Szczepański, MD PhD, Andreas E. Kulozik, MD PhD, Michał Witt, MD PhD, Malgorzata Dawidowska, PhD

Blood (2017) 130 (Supplement 1): 1446.

https://doi.org/10.1182/blood.V130.Suppl_1.1446.1446

Published: 2017

Journal Articles

Subcutaneous Compared to Intravenous Administration of Rituximab Plus CHOP in Patients with Diffuse Large B-Cell Lymphoma — a Study By the Polish Lymphoma Research Group

Ewa Paszkiewicz-Kozik, Monika Dlugosz-Danecka, MD PhD, Paweł J. Robak, MD, Elżbieta Wojciechowska-Lampka, MD, Monika Swierkowska-Czeneszew, MD, Joanna Tajer, MD PhD, Joanna Romejko-Jarosinska, MD PhD, Katarzyna Domanska-Czyz, MD, Marcin Szymanski, MD, Marta Morawska, MD, Lukasz Targonski, MD, Michal Osowiecki, MD, Beata Ostrowska, MDPhD, Anna Paulina Dabrowska-Iwanicka, MD PhD, Jan Walewski, MD PhD

Blood (2017) 130 (Supplement 1): 5217.

https://doi.org/10.1182/blood.V130.Suppl_1.5217.5217

Published: 2017

Journal Articles

Randomized, Double-Blind Trial of Ferumoxytol Compared to Ferric Carboxymaltose for Treatment of Iron Deficiency Anemia: Safety and Efficacy

Michael Auerbach, MD, William E Strauss, MD, Iain C. Macdougall, MD, Kristine Bernard, MPH, Robert F Kaper, MD, Glenn M Chertow, MD MPH, Zhu Li, PhD, Anton Trochanov, MD, Naomi V Dahl, PharmD, Julie Krop, MD

Blood (2017) 130 (Supplement 1): 3500.

https://doi.org/10.1182/blood.V130.Suppl_1.3500.3500

Published: 2017

Journal Articles

Nonconventional Gene Expression within the NF-κb Signaling Pathway Induced By Poly(propylene)Imine Glycodendrimers in Chronic Lymphocytic Leukemia Cells

Ida Franiak-Pietryga, PhD, Kinga Ostrowska, Ms.C., Dietmar Appelhans, PhD, Henryk Maciejewski, PhD, Maria Bryszewska, Professor, Tadeusz Robak, MD PhD, Jacek Trelinski, MD Professor, Maciej Borowiec, Professor

Blood (2016) 128 (22): 5595.

https://doi.org/10.1182/blood.V128.22.5595.5595

Published: 2016

Journal Articles

Final Results of a Phase 2 Trial of Extended Treatment (tx) with Carfilzomib (CFZ), Lenalidomide (LEN), and Dexamethasone (KRd) Plus Autologous Stem Cell Transplantation (ASCT) in Newly Diagnosed Multiple Myeloma (NDMM)

Todd Zimmerman, MD, Noopur S. Raje, Ravi Vij, Donna Reece, MD, Jesus G. Berdeja, MD, Leonor A Stephens, PhD, Kathryn McDonnell, Cara A. Rosenbaum, MD, Jagoda Jasielec, MD, Paul G Richardson, MD, Sandeep Gurbuxani, Jennifer Nam, Erica Severson, Brittany D. Wolfe, MMS, PA-C, Shaun Rosebeck, PhD, Andrew Stefka, Dominik Dytfeld, MD PhD, Kent Griffith, PhD, Andrzej Jakubowiak, MDPhD

Blood (2016) 128 (22): 675.

https://doi.org/10.1182/blood.V128.22.675.675

Published: 2016

Journal Articles

Acute Leukemia of Ambiguous Lineage: A Comprehensive Survival Analysis Enables Designing New Treatment Strategies

Ondrej Hrusak, MD PhD, Valerie De Haas, MD PhD, Ales Luks, Iveta Janotova, Ester Mejstrikova, MD PhD, Kirsten Bleckmann, MD, Anja Moricke, MD, Julie Irving, PhD, Benigna Konatkowska, Thomas B. Alexander, MD MPH, Hiroto Inaba, MD PhD, Kjeld Schmiegelow, MD DMSc, Simone Stokley, FRCPath,, Jorge Gabriel Rossi, PhD, Maria Sara Felice, MD PhD, Luciano Dalla-Pozza, MB BS FRACP, Jessa Morales, Michael Dworzak, MD, Barbara Buldini, MD, Giuseppe Basso, Myriam Campbell, Maria Elena Cabrera, Neda Marinov, Sarah Elitzur, MD, Shai Izraeli, MD, Drorit Luria, PhD, Tamar Feuerstein, PhD, Alexandra Kolenova, MD PhD, Peter Svec, Elena Kreminska, Karen R. Rabin, MD, Sophia Polychronopoulou, MD PhD, Elaine da Costa, Hanne Vibeke Marquart, MD PhD, Antonis Kattamis, MD, Richard Ratei, Dirk Reinhardt, MD PhD, Anthony V Moorman, PhD, Martin Schrappe, MD, Jan Stary, MD D.Sc.

Blood (2016) 128 (22): 584.

https://doi.org/10.1182/blood.V128.22.584.584

Published: 2016

Journal Articles

Natural History of Relapsed Myeloma, Refractory to Immunomodulatory Drugs and Proteasome Inhibitors: A Multicenter IMWG Study

Shaji Kumar, MD, Meletios A Dimopoulos, Efstathios Kastritis, MD, Evangelos Terpos, Hareth Nahi, Hartmut Goldschmidt, MD, Jens Hillengass, MD, Xavier Leleu, Meral Beksac, MD, Melissa Alsina, MD, Albert Oriol, MD, Michele Cavo, MD, Enrique M. Ocio, MD PhD, Maria Victoria Mateos, Elizabeth K. O'Donnell, MD, Ravi Vij, MD MBA, Henk M. Lokhorst, MD PhD, Niels W.C.J. van de Donk, MD PhD, Chang-Ki Min, Tomer Mark, MD MSc, Ingemar Turesson, MD, PhD, Markus Hansson, MD, Heinz Ludwig, Sundar Jagannath, MD, Michel Delforge, MD PhD, Charalampia Kyriakou, MD PhD, Parameswaran Hari, MBBS, MD MRCP, Ulf-Henrik Mellqvist, MD PhD, Saad Z Usmani, MD FACP, Dominik Dytfeld, MD PhD, Ashraf Z Badros, MD, Philippe Moreau, Kihyun Kim, MD PhD, Paula Rodriguez Otero, MD, Jae Hoon Lee, MD, Chaim Shustik, MD, Daniel Waller, PhD, Wee Joo Chng, MD PhD, Shuji Ozaki, MD PhD, Je-Jung Lee, Javier de la Rubia, Hyeon Seok Eom, MD PhD, Laura Rosinol, MD PhD, Juan José Lahuerta, MD PhD, Anna Sureda, MD PhD, Jin Seok Kim, MD PhD, Brian G.M. Durie, MD

Blood (2016) 128 (22): 4414.

https://doi.org/10.1182/blood.V128.22.4414.4414

Published: 2016

Journal Articles

HLA Class I-Specific Effects in AML with Mutated Nucleophosmin

Kateřina Kuželová, PhD, Christoph Röllig, MD, Zdenek Racil, MD, Juliane S. Stickel, MD, Barbora Brodská, PhD, Johannes Schetelig, MD MSc, Christian Thiede, MD, Gerhard Ehninger, MD, Grzegorz Helbig, MD PhD, Slawomira Kyrcz-Krzemien, Prof, Jiri Mayer, Petr Cetkovsky, MD MBA, PhD

Blood (2016) 128 (22): 5230.

https://doi.org/10.1182/blood.V128.22.5230.5230

Published: 2016

Journal Articles

Comparative Proteomic Profiling of Sera from Patients with Refractory Multiple Myeloma Reveals Pathways and Biomarkers Predicting Response to Bortezomib-Based Therapy

Dominik Dytfeld, MD PhD, Magdalena Luczak, PhD, Tomasz Szczepaniak, MD, Anna Przybylowicz-Chalecka, Msc, Blazej Ratajczak, MSc, Joanna Czerwinska-Rybak, MSc, Adam Nowicki, MD PhD, Monika Joks, MD PhD, Andrzej Jakubowiak, MD PhD, Mieczyslaw Komarnicki, MD PhD

Blood (2016) 128 (22): 2092.

https://doi.org/10.1182/blood.V128.22.2092.2092

Published: 2016

NARROW

An Open-Label, Phase 2 Study of KRT-232, a First-in-Class, Oral Small Molecule Inhibitor of MDM2, for the Treatment of Patients with Myelofibrosis (MF) Who Have Previously Received Treatment with a JAK Inhibitor

The Gut Microbiome Regulates Psychological Stress-Induced Inflammation in Sickle Cell Disease

Immune Tolerance Induction (ITI) in Paediatric and Adult Patients with Haemophilia a (HA) and High-Titre (HT) Factor VIII (FVIII) Inhibitor - Real Life Data

Analysis of Predictive Factors for Early Response to Ruxolitinib in 266 Patients with Myelofibrosis from the Polish Adult Leukemia Group (PALG) Registry

miR106a-363 Cluster Has Oncogenic Potential in Childhood T-Cell Acute Lymphoblastic Leukemia

Staining Pattern of Leukemic Lymphoblasts for Coagulation Factor XIII Subunit a Correlates with Clinical Outcome and B-Other Genotype in Childhood Acute Lymphoblastic Leukemia

The Prognostic Impact of t(14;16) in Multiple Myeloma: A Multicenter Retrospective Study of 213 Patients. Is It Time to Revise the Revised ISS?

Outcome of Children Relapsing after First Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Acute Myeloid Leukemia: A Retrospective I-BFM Analysis of 336 Children between 2005 and 2016

Concomitant Medications and Comorbidities Affect Early Response in CML Patients Treated with Imatinib: A Retrospective Analysis of 340 Patients from the Polish Adult Leukemia Group (PALG) Registry

Improvement of the Treatment Results in Childhood Acute Myeloid Leukemia in Poland from 1983 to 2017

miRNA Profiling in Pediatric T-ALL with Use of Next-Generation Sequencing: Focus on T-ALL Pathobiology and Heterogeneity

PTEN Alterations Are Related to Unfavorable Prognosis in Children with T-Cell Acute Lymphoblastic Leukemia Treated According to ALL IC-BFM Protocols

Subcutaneous Compared to Intravenous Administration of Rituximab Plus CHOP in Patients with Diffuse Large B-Cell Lymphoma — a Study By the Polish Lymphoma Research Group

Randomized, Double-Blind Trial of Ferumoxytol Compared to Ferric Carboxymaltose for Treatment of Iron Deficiency Anemia: Safety and Efficacy

Nonconventional Gene Expression within the NF-κb Signaling Pathway Induced By Poly(propylene)Imine Glycodendrimers in Chronic Lymphocytic Leukemia Cells

Final Results of a Phase 2 Trial of Extended Treatment (tx) with Carfilzomib (CFZ), Lenalidomide (LEN), and Dexamethasone (KRd) Plus Autologous Stem Cell Transplantation (ASCT) in Newly Diagnosed Multiple Myeloma (NDMM)

Acute Leukemia of Ambiguous Lineage: A Comprehensive Survival Analysis Enables Designing New Treatment Strategies

Natural History of Relapsed Myeloma, Refractory to Immunomodulatory Drugs and Proteasome Inhibitors: A Multicenter IMWG Study

HLA Class I-Specific Effects in AML with Mutated Nucleophosmin

Comparative Proteomic Profiling of Sera from Patients with Refractory Multiple Myeloma Reveals Pathways and Biomarkers Predicting Response to Bortezomib-Based Therapy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only